Cinclus Pharma Holding Ab
Clinical trials sponsored by Cinclus Pharma Holding Ab, explained in plain language.
-
New GERD drug aims to keep esophagus healed longer
Disease control Not yet recruitingThis phase 3 trial tests whether a new drug, linaprazan glurate, can keep the esophagus healed in people with healed erosive esophagitis from GERD, compared to the standard drug lansoprazole. About 1050 adults who were healed in a prior trial will take either high or low dose lin…
Phase: PHASE3 • Sponsor: Cinclus Pharma Holding AB • Aim: Disease control
Last updated May 17, 2026 06:46 UTC
-
New GERD drug aims to heal esophagus faster than current treatment
Disease control Not yet recruitingThis study tests a new medicine called linaprazan glurate to see if it heals esophagus damage from GERD better than the standard drug lansoprazole. About 500 adults with erosive esophagitis will take either the new drug or the standard one for up to 8 weeks. Doctors will use came…
Phase: PHASE3 • Sponsor: Cinclus Pharma Holding AB • Aim: Disease control
Last updated May 15, 2026 11:56 UTC